beta-Thalassemia.
Origa R.
Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. Epub 2016 Nov 3.
The Clinical Phenotypes of Alpha Thalassemia.
Lal A, Vichinsky E.
Hematol Oncol Clin North Am. 2023 Apr;37(2):327-339. doi: 10.1016/j.hoc.2022.12.004.
Thalassemia, a human blood disorder.
Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, Khawaja S, Andleeb S, Hassan MU.
Braz J Biol. 2021 Sep 3;83:e246062. doi: 10.1590/1519-6984.246062. eCollection 2021.
Laboratory diagnosis of thalassemia.
Brancaleoni V, Di Pierro E, Motta I, Cappellini MD.
Int J Lab Hematol. 2016 May;38 Suppl 1:32-40. doi: 10.1111/ijlh.12527. Epub 2016 May 16.
Homozygous mild beta-thalassaemia promoter transversion -71 C>T HBB:c.-121 C>T.
Hassan SM, Alrawas A, Al Khanbashi L, Wali Y.
BMJ Case Rep. 2023 Apr 4;16(4):e254416. doi: 10.1136/bcr-2022-254416.
Beta-thalassaemia.
Thein SL.
Baillieres Clin Haematol. 1998 Mar;11(1):91-126. doi: 10.1016/s0950-3536(98)80071-1.
Thalassaemia intermedia.
Wainscoat JS, Thein SL, Weatherall DJ.
Blood Rev. 1987 Dec;1(4):273-9. doi: 10.1016/0268-960x(87)90029-4.
Advances in screening of thalassaemia.
Gao J, Liu W.
Clin Chim Acta. 2022 Sep 1;534:176-184. doi: 10.1016/j.cca.2022.08.001. Epub 2022 Aug 3.
Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.
Padhani ZA, Gangwani MK, Sadaf A, Hasan B, Colan S, Alvi N, Das JK.
Cochrane Database Syst Rev. 2023 Nov 17;11(11):CD011626. doi: 10.1002/14651858.CD011626.pub3.
Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis.
Pelusi S, Iuculano F, Lombardi R, Francione P, Gianelli U, Fracanzani AL, Fargion S.
Intern Emerg Med. 2019 Aug;14(5):763-766. doi: 10.1007/s11739-018-1947-2. Epub 2018 Sep 14.
